Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Revision of Appendix 3B lodged 16 September 2015 New issue announcement, application for quotation of additional securities and agreementInformation or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity |
PARAGON CARE LIMITED |
ABN |
76 064 551 426 |
We (the entity) give ASX the following information.
Part 1 - All issuesYou must complete the relevant sections (attach sheets if there is not enough space).
1 | +Class of +securities issued or to be issued | Fully paid ordinary shares |
2 | Number of +securities issued or to be issued (if known) or maximum number which may be issued | 525,920 |
3 | Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) | Fully paid ordinary shares to rank equally in all respects with existing ordinary shares. |
4 | Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities? If the additional +securities do not rank equally, please state:
| Fully paid ordinary shares ranking equally in all respects with existing ordinary shares. |
5 | Issue price or consideration | $0.9020 per fully paid ordinary share |
6 | Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) |
|
6a | Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i | Yes |
6b | The date the security holder resolution under rule 7.1A was passed | 18 November 2016 |
6c | Number of +securities issued without security holder approval under rule 7.1 | 525,920, being the above issues. |
6d | Number of +securities issued with security holder approval under rule 7.1A | Nil |
6e | Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) | Nil |
6f | Number of +securities issued under an exception in rule 7.2 | 764,447 |
6g | If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. | N/A |
6h | If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements | N/A |
6i | Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements | 40,728,582 Refer Annexure 1 |
7 | +Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. | 14 August 2017 |
Number | +Class |
165,543,929 | Fully paid ordinary shares |
Number and +class of all
+securities quoted on ASX (including the +securities in section 2 if applicable)
Number
+Class
N/A
N/A
Number and +class of all
+securities not quoted on ASX (including the +securities in section 2 if applicable)
No change to dividend policy.
Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)
You need only complete this section if you are applying for quotation of securities
34 | Type of +securities (tick one) |
(a) | +Securities described in Part 1 |
(b) | All other +securities Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities |
Paragon Care Ltd. published this content on 14 August 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 14 August 2017 03:51:09 UTC.
Original documenthttp://www.paragoncare.com.au/wp-content/uploads/PGC_Appendix-3B-Medtek-Western-Bio-2017-08-14.pdf
Public permalinkhttp://www.publicnow.com/view/87C00D5F3068D569148C0FD360FFB133D9D76964